Akèy › Sklerodèm › Maryland › Baltimore
Etid klinik pou Sklerodèm nan Baltimore, MD
6 etid pou Sklerodèm ap chèche patisipan nan sit nan ak bò kote Baltimore (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
Ap rekriteFaz 3
- Johns Hopkins Hospital, Baltimore
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
Ap rekriteFaz 2
- Johns Hopkins Asthma and Allergy Center, Baltimore
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
Ap rekriteFaz 1
- Johns Hopkins Hospital, Baltimore
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Ap rekriteFaz 2/3
- GSK Investigational Site, Baltimore
Platform Clinical Study for Conquering Scleroderma
Ap rekriteFaz 2
- Johns Hopkins University School of Medicine, Baltimore
Etid Sklerodèm nan lòt vil
- New York City, NY11 etid
- Ann Arbor, MI10 etid
- Chicago, IL10 etid
- Houston, TX9 etid
- Los Angeles, CA7 etid
- Boston, MA7 etid
- Durham, NC7 etid
- New Orleans, LA6 etid
- Philadelphia, PA6 etid
- Dallas, TX5 etid
- Pittsburgh, PA5 etid
- Miami, FL4 etid
Lòt etid nan Baltimore
- Kansè Poumon ki pa ti selil60 etid
- Kansè nan tete47 etid
- Kansè pwostat42 etid
- Kansè poumon40 etid
- Kansè (tout kalite)38 etid
- Kansè pankreyas32 etid
- Kansè kolorektal31 etid
- Kansè Metastatik28 etid
- Obèsite25 etid
- Kansè vejik24 etid
- Ensifizyans kadyak24 etid
- Akidan serebavaskilè22 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 1, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.